These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22161803)

  • 1. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.
    Ascenzi MG; Liao VP; Lee BM; Billi F; Zhou H; Lindsay R; Cosman F; Nieves J; Bilezikian JP; Dempster DW
    J Bone Miner Res; 2012 Mar; 27(3):702-12. PubMed ID: 22161803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-osteoporotic women with low-trauma fracture present altered birefringence in cortical bone.
    Ascenzi MG; Chin J; Lappe J; Recker R
    Bone; 2016 Mar; 84():104-112. PubMed ID: 26514952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB; Kisiel M; Adachi JD; Fraher LJ; Watson PH
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
    Hansen S; Hauge EM; Beck Jensen JE; Brixen K
    J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen orientation patterns in human secondary osteons, quantified in the radial direction by confocal microscopy.
    Ascenzi MG; Lomovtsev A
    J Struct Biol; 2006 Jan; 153(1):14-30. PubMed ID: 16399238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women.
    Adami S
    Curr Med Res Opin; 2008 Nov; 24(11):3259-74. PubMed ID: 18940041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
    J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
    Shen L; Xie X; Su Y; Luo C; Zhang C; Zeng B
    PLoS One; 2011; 6(10):e26267. PubMed ID: 22022584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study.
    Zanchetta JR; Bogado CE; Cisari C; Aslanidis S; Greisen H; Fox J; Lems W
    Curr Med Res Opin; 2010 Nov; 26(11):2627-33. PubMed ID: 20923256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study.
    Garnero P; Bauer DC; Mareau E; Bilezikian JP; Greenspan SL; Rosen C; Black D
    J Bone Miner Res; 2008 Sep; 23(9):1442-8. PubMed ID: 18442311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic imaging of treatment in osteoporosis: PTH].
    Ito M
    Clin Calcium; 2011 Jul; 21(7):1067-73. PubMed ID: 21719988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
    Schafer AL; Burghardt AJ; Sellmeyer DE; Palermo L; Shoback DM; Majumdar S; Black DM
    Osteoporos Int; 2013 Oct; 24(10):2591-601. PubMed ID: 23589163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of OSteoporosis (PaVOS)- study protocol for a randomized controlled trial.
    Jepsen DB; Ryg J; Jørgensen NR; Hansen S; Masud T
    Trials; 2018 Mar; 19(1):186. PubMed ID: 29548300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray diffraction and electron microscope study of osteons during calcification.
    Ascenzi A; Bonucci E; Ripamonti A; Roveri N
    Calcif Tissue Res; 1978 May; 25(2):133-43. PubMed ID: 667661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.